首页> 外国专利> DESFERRI-EXOCHELIN FOR THE TREATMENT OF ATHEROSCLEROSIS AND VASCULAR INJURY BY PREVENTION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION

DESFERRI-EXOCHELIN FOR THE TREATMENT OF ATHEROSCLEROSIS AND VASCULAR INJURY BY PREVENTION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION

机译:去铁-表儿茶素通过预防血管平滑肌细胞增生来治疗动脉粥样硬化和血管损伤

摘要

A method for the treatment of atherosclerosis and vascular injury using exochelins, and more particularly exochelins of Mycobacterium tuberculosis, to prevent vascular smooth muscle cell proliferation. Delivery of an effective amount of a desferri-Exochelins to a living organism such as an animal or a human by oral, intravenous or direct delivery to the site at which the effect is desired will protect blood vessels in a living organism from restenosis following angioplasty or vascular surgery and will prevent or slow the progression of atherosclerosis, systemic hypertension, radiation damage to the vasculature, stenosis or closure of bypass grafts to the coronary arteries or other blood vessels following a surgical procedure and various forms of pulmonary hypertension.
机译:一种使用exochelin,尤其是结核分枝杆菌的exochelins治疗动脉粥样硬化和血管损伤的方法,以防止血管平滑肌细胞增殖。通过口服,静脉内或直接递送至需要效果的部位,将有效量的去铁蛋白-Exochelins递送至诸如动物或人的活生物体将保护活生物体中的血管免于血管成形术或随后的再狭窄。血管外科手术,将预防或减缓动脉粥样硬化,全身性高血压,对血管的放射损伤,狭窄或在外科手术和各种形式的肺动脉高压后关闭对冠状动脉或其他血管的旁路移植物。

著录项

  • 公开/公告号EP1021189B1

    专利类型

  • 公开/公告日2002-05-02

    原文格式PDF

  • 申请/专利权人 KEYSTONE BIOMEDICAL INC.;

    申请/专利号EP19980907415

  • 发明设计人 HORWITZ LAWRENCE D.;

    申请日1998-02-06

  • 分类号A61K31/55;

  • 国家 EP

  • 入库时间 2022-08-22 00:35:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号